LifeStance Health Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 08, 2023 at 06:09 am
Share
LifeStance Health Group, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 262.9 million compared to USD 217.56 million a year ago. Net loss was USD 61.58 million compared to USD 37.85 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.11 a year ago.
For the nine months, sales was USD 775.06 million compared to USD 630.18 million a year ago. Net loss was USD 141.3 million compared to USD 168.91 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.48 a year ago.
LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LIFESTANCE HEALTH GROUP, INC. 
